FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 341:893-900 September 16, 1999 Number 12 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF Purchase this article Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

The past two decades have witnessed an increase in the number of patients who are immunocompromised as a consequence of a primary or secondary immunodeficiency disorder or from the use of agents that depress one or more components of the immune system. Broadly defined, an immunocompromised host has an alteration in phagocytic, cellular, or humoral immunity that increases the risk of an infectious complication or an opportunistic process such as a lymphoproliferative disorder or cancer.¹ Patients may also be immunocompromised if they have an alteration or breach of their skin or mucosal defense barriers that permits microorganisms to cause either . . . [Full Text of this Article]

Fever, Immunosuppression, and Infection

Need for Urgent Evaluation and Intervention

Dominant Organisms Associated with Infection

Initial Evaluation of Fever

Management of Infectious Complications

Source Information

From the Department of Medicine, Children's Hospital, and the Department of Pediatrics, Harvard Medical School — both in Boston.

Address reprint requests to Dr. Pizzo at Children's Hospital, 300 Longwood Ave., Boston, MA 02115, or at pizzo_p@a1.tch.harvard.edu.

References

Related Letters:

Fever in Immunocompromised Patients
Serody J. S., Pizzo P. A.
Extract | Full Text  
N Engl J Med 2000; 342:217-218, Jan 20, 2000. Correspondence

This article has been cited by other articles:

• Viget, N, Vernier-Massouille, G, Salmon-Ceron, D, Yazdanpanah, Y, Colombel, J-F (2008). Opportunistic infections in patients with inflammatory bowel disease: prevention and diagnosis. Gut 57: 549-558 [Abstract] [Full Text]  
• Stolz, D., Stulz, A., Muller, B., Gratwohl, A., Tamm, M. (2007). BAL Neutrophils, Serum Procalcitonin, and C-Reactive Protein To Predict Bacterial Infection in the Immunocompromised Host. Chest 132: 504-514 [Abstract] [Full Text]  
• Tavares, E., Minano, F. J., Maldonado, R., Dascombe, M. J. (2006). Endotoxin fever in granulocytopenic rats: evidence that brain cyclooxygenase-2 is more important than circulating prostaglandin E2. J. Leukoc. Biol. 80: 1375-1387 [Abstract] [Full Text]  
• Basu, S. K., Fernandez, I. D., Fisher, S. G., Asselin, B. L., Lyman, G. H. (2005). Length of Stay and Mortality Associated With Febrile Neutropenia Among Children With Cancer. JCO 23: 7958-7966 [Abstract] [Full Text]  
• Tavares, E., Maldonado, R., Ojeda, M. L., Minano, F. J. (2005). Circulating Inflammatory Mediators during Start of Fever in Differential Diagnosis of Gram-Negative and Gram-Positive Infections in Leukopenic Rats. CVI 12: 1085-1093 [Abstract] [Full Text]  
• Clark, O. A.C., Lyman, G. H., Castro, A. A., Clark, L. G.O., Djulbegovic, B. (2005). Colony-Stimulating Factors for Chemotherapy-Induced Febrile Neutropenia: A Meta-Analysis of Randomized Controlled Trials. JCO 23: 4198-4214 [Abstract] [Full Text]  
• Patel, U. D., Hollander, H., Saint, S. (2004). Index of Suspicion. NEJM 350: 1990-1995 [Full Text]  
• Ottinger, H. D., Ferencik, S., Beelen, D. W., Lindemann, M., Peceny, R., Elmaagacli, A. H., Husing, J., Grosse-Wilde, H. (2003). Hematopoietic stem cell transplantation: contrasting the outcome of transplantations from HLA-identical siblings, partially HLA-mismatched related donors, and HLA-matched unrelated donors. Blood 102: 1131-1137 [Abstract] [Full Text]  
• Murono, K., Hirano, Y., Koyano, S., Ito, K., Fujieda, K. (2003). Molecular comparison of bacterial isolates from blood with strains colonizing pharynx and intestine in immunocompromised patients with sepsis. J Med Microbiol 52: 527-530 [Abstract] [Full Text]  
• Thompson, K. H., Orvig, C. (2003). Boon and Bane of Metal Ions in Medicine. Science 300: 936-939 [Abstract] [Full Text]  
• Linkin, D. R., Fishman, N. (2003). Ciprofloxacin versus Tobramycin for Neutropenic Fevers. ANN INTERN MED 138: 435-436 [Full Text]  
• Stone, R. M. (2002). The Difficult Problem of Acute Myeloid Leukemia in the Older Adult. CA Cancer J Clin 52: 363-371 [Abstract] [Full Text]  
• Peacock, J. E. Jr., Herrington, D. A., Wade, J. C., Lazarus, H. M., Reed, M. D., Sinclair, J. W., Haverstock, D. C., Kowalsky, S. F., Hurd, D. D., Cushing, D. A., Harman, C. P., Donowitz, G. R. (2002). Ciprofloxacin plus Piperacillin Compared with Tobramycin plus Piperacillin as Empirical Therapy in Febrile Neutropenic Patients: A Randomized, Double-Blind Trial. ANN INTERN MED 137: 77-87 [Abstract] [Full Text]  
• Baden, L. R., Rubin, R. H. (2002). Fever, Neutropenia, and the Second Law of Thermodynamics. ANN INTERN MED 137: 123-124 [Full Text]  
• Donowitz, G. R., Maki, D. G., Crnich, C. J., Pappas, P. G., Rolston, K. V.I. (2001). Infections in the Neutropenic Patient-- New Views of an Old Problem. ASH Education Book 2001: 113-139 [Abstract] [Full Text]  
• Serody, J. S., Pizzo, P. A. (2000). Fever in Immunocompromised Patients. NEJM 342: 217-218 [Full Text]